Bedford, United Kingdom

Kenneth James Beresford

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kenneth James Beresford: Innovator in Proliferative Disorder Treatment

Introduction: Kenneth James Beresford is a noted inventor based in Bedford, GB, recognized for his contributions to the field of medical innovation. With a keen focus on addressing proliferative disorders, Beresford's work is paramount in advancing therapeutic methods.

Latest Patents: Kenneth holds one significant patent for a compound designed for use in the treatment of proliferative disorders, including cancer. This innovative compound is characterized by a specific formula, showcasing Beresford's commitment to improving treatment options for patients suffering from serious health conditions.

Career Highlights: Throughout his career, Kenneth has dedicated himself to research and development within the pharmaceutical and therapeutic domains. His role at Spear Therapeutics Limited is instrumental in driving forward drug development strategies aimed at curing proliferative diseases.

Collaborations: Collaborating with esteemed colleagues such as Gerard Andrew Potter and Philip Huxley, Kenneth has fostered an environment of innovation and shared expertise at Spear Therapeutics Limited. Their joint efforts contribute significantly to the advancement of research in therapeutics and drug development.

Conclusion: Kenneth James Beresford stands out as a vital figure in the realm of medical innovations. His patent for a compound that aids in the treatment of proliferative disorders epitomizes the transformative potential of dedicated research and collaboration in the medical field. Through his work, Beresford continues to pave the way for breakthroughs that could enhance patient care and treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…